Methods using TCF -II

Abstract

The present invention provides an agent for preventing and/or treating cachexia comprising TCF-II as an effective ingredient. An agent for preventing and treating cachexia caused by cancer, acquired immunodeficient syndrome (AIDS), cardiac diseases, infectious disease, shock, burn, endotoxinemia, organ inflammation, surgery, diabetes, collagen diseases, radiotherapy, chemotherapy is provided by the present invention.

1 - 2 . (canceled)  
   
   
       3 . A method for increasing hematocrit levels in a patient having anemia comprising the step of administering to a patient with anemia a therapeutically effective amount of Tumor Cytotoxic Factor II, wherein the Tumor Cytotoxic Factor II increases hematocrit levels in the patient.  
   
   
       4 . The method of  claim 3 , further comprising the step of determining the level of hematocrit in the patient after the administration of Tumor Cytotoxic Factor II.  
   
   
       5 . The method of  claim 3 , wherein the therapeutically effective amount of Tumor Cytotoxic Factor II is a dosage between about 0.3 mg/kg body weight/day and about 30 mg/kg body weight/day.  
   
   
       6 . The method of  claim 3 , wherein the therapeutically effective amount of Tumor Cytotoxic Factor II is a dosage between about 0.6 mg/day and about 600 mg/day.  
   
   
       7 . The method of  claim 3 , wherein Tumor Cytotoxic Factor II is dispersed in a composition comprising saline or citric acid.  
   
   
       8 . The method of  claim 3 , wherein Tumor Cytotoxic Factor II is administered by injection.  
   
   
       9 . The method of  claim 3 , wherein the patient is a human patient.